Login to Your Account

Financings Roundup

Blaze Bioscience Raises $5M in Series A for Tumor Paint

By Marie Powers
Staff Writer

Monday, June 11, 2012
Less than two years after its founding and 10 months after licensing its technology from Seattle's Fred Hutchinson Cancer Research Center, privately held Blaze Bioscience Inc. raised $5 million in a Series A financing.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription